Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
Clinical trial NCT06102759 · RECRUITING
Trial details
- NCT number
- NCT06102759
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-10
- Primary completion
- 2026-10-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.